Conference: 4th Annual Gene Therapy Immunogenicity Summit
Precision will be at this year’s 4th Annual Gene Therapy Immunogenicity Summit, September 5 – 7, 2023, in Boston, MA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the development for cell and gene therapies.
Connect with our Advanced Therapy experts!
- Schedule a meeting with one our our experts
- Stop by Precision’s booth
- Be sure to attend Precision’s own, Travis Harrison’s presentation on September 6th, 2023, at 9:30 AM EDT
You can register for the 4th Annual Gene Therapy Immunogenicity Summit below:
White Paper: Cell and Gene Therapies: How High Can Prices Go?
The concept of optimizing CGT value propositions begs the question of what is reasonable when it comes to breakthrough science and unprecedented therapeutic solutions. Can a $5 million price tag be justified? What about $10 million?
This white paper is based on a webinar convened by PRECISIONadvisors, focusing on cell and gene therapy (CGT) pricing. The webinar featured two in-house experts from the PRECISIONadvisors Global Pricing & Market Access practice: Richard Macaulay, Senior Vice President and David Carr, Senior Director.
On Demand: The Future of Cell Therapy Development and Delivery
Sponsored by Precision ADVANCE, this Endpoints webinar convened leading advanced therapy experts to discuss the future of cell therapy development and delivery. This discussion was moderated by John Khoury: EVP (Project Farma), and included insights from Chris McDonald: Global Head of Tech Ops (Kite Pharma), Mark Frattini: CMO (Cellectis), Jason Foster: CEO & ED (Ori Biotech), and Phil Cyr: SVP (Precision Value & Health).
Conference: CAR-TCR Summit, 2023
Precision will be at this year’s CAR-TCR Summit August 29 – September 1, 2023, in Boston, MA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization of cell therapies.
Speaking Engagements
Detailed descriptions for each speaking engagement are included below.
- Precision ADVANCE will hold a welcome reception on August 29, 2023, at 5:30 pm.
- Project Farma will be facilitating a Manufacturing track panel discussion “Keys to Success for a Commercial – Ready Cell Therapy Facility” on August 30, 2023, 4:30 – 5:00 pm.
- Precision ADVANCE will be facilitating an Early-Stage Clinical Strategy track panel discussion “Strategies for Successful Clinical Development of Cell Therapies” on August 30, 2023, 4:30 – 5:00 pm.
- Precision ADVANCE will have a plenary speaking position “The Journey of Commercializing Cell Therapies” on August 31, 2023, 8:05 – 8:50 am.
Connect with our Advanced Therapy experts
- Visit us at booth 90 in the exhibition area
- Schedule in-person or virtual meetings with one of our experts
- Attend our ADVANCE-sponsored Welcome Reception on August 29, 2023, at 5:30 PM ET
White Paper: mRNA Innovation Is Revolutionizing Disease Prevention
The first FDA approved mRNA product was decades in the making, following many iterations throughout history the first mRNA vaccine in the US was brought to life. This achievement delivered aid to patients and healthcare providers during the most critical public health crisis in recent years. Since then, researchers have been operating at incredible speeds to develop more novel mRNA treatment options for patients, across many indications.
In this white paper, Anshul Mangal, President of Project Farma & Precision ADVANCE and Chad Salisbury, Senior Vice President of Project Farma (PF), discuss the mRNA revolution and its impact on the future of disease prevention and treatment.